Stock Events

Stock Events

Eliem Therapeutics (ELYM) Q3 2024 Earnings

14AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.81

-1.21

-0.6

0

Details

Expected EPS

N/A

Actual EPS

-1.81

Surprise EPS

-1.81

Surprise Percent

+∞%

Description

Eliem Therapeutics (ELYM) has reported earnings of -1.81 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.